A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast

Japanese Journal of Cancer Research

Volumn 89, Issue 12, 1998, Pages 1358-1373

  Hasebe, Takahiro ^a   Imoto, Shigeru ^b   Sasaki, Satoshi ^a   Mukai, Kiyoshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Breast; Fibrotic focus; Invasive ductal carcinoma; Prognosis; Staging

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CELL NUCLEUS; CELL STRUCTURE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LIPID STORAGE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MITOSIS; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SKIN METASTASIS; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0032465074     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00534.x     Document Type: Article

References (26)

1. Fisher, B., Slack, N. H. and Bross, I. D. J. Cooperating investigators. Cancer of the breast: size of neoplasm and prognosis. Cancer, 24, 1071-1080 (1969).
2. Say, C. C. and Donegan, W. L. Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes. Cancer, 34, 468-471 (1974).
3. Bloom, H. J. G. and Richardson, W. W. Histological grading and prognosis in breast cancer. Br. J. Cancer, 11, 359-377 (1957).
4. Bloom, H. J. G. and Field, J. R. Impact of tumor grade and host resistance on survival of women with breast cancer. Cancer, 28, 1580-1589 (1971).
5. Fisher, E. R., Palekar, A., Rockette, H., Redmond, C. K. and Fisher, B. Pathologic findings from the national surgical adjuvant breast project (Protocol No.4). V. Significance of axillary nodal micro- and macrometastases. Cancer, 42, 2032-2038 (1978).
6. Fisher, B., Bauer, M., Wickerham, L., Redmond, C. K. and Fisher, E. R. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer, 52, 1551-1557 (1983).
7. Fallenius, A. G., Auer, G. U. and Carstensen, J. M. Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer, 62, 331-341 (1988).
8. Witzig, T. E., Gonchoroff, N. J., Therneau, T., Gibertson, D. T., Wold, L. E., Grant, C., Grande, J., Katzmann, J. A., Ahmann, D. L. and Ingle, J. N. DNA content flow cytometry as a prognostic factor for node-positive breast cancer. Cancer, 68, 1781-1788 (1991).
9. 3H-thymidine labelling index. Int. J. Cancer, 74, 122-127 (1997).
10. Tsuda, H., Hirohashi, S., Shimosato, Y., Hirota, T., Tsugane, S., Yamamoto, H., Miyajijma, N., Toyoshima, K., Yamamoto, T., Yokota, J., Yoshida, T., Sakamoto, H., Terada, M. and Sugimura, T. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res., 49, 3104-3108 (1989).
11. Clark, G. M. and McGuire, W. L. Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res.,51, 944-948 (1991).
12. Isola, J. J., Kallioniemi, O.-P., Chu, L. W., Fuqua, S. A. W., Hilsenbeck, S. G., Osborne, C. K. and Waldman, F. M. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol.,147, 905-911 (1995).
13. De Marchis, L., Contegiacomo, A., D'Amico, C., Palmirotta, R., Pizzi, C., Ottini, L., Mastranzo, P., Figliolini, M., Petrella, G., Amanti, C., Battista, P., Brianco, A. R., Grati, L., Cama, A. and Mariani-Constantini, R. Microsatellite instability is correlated with lymph node-positive breast cancer. Clin. Cancer Res.,3, 241-248 (1997).
14. Hasebe, T., Tsuda, H., Tsubono, Y., Imoto, S. and Mukai, K. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation. Jpn. J. Cancer Res.,88, 590-599 (1997).
15. Hasebe, T., Tsuda, H., Hirohashi, S., Shimosato, Y., Tsubono, Y., Yamamoto, H. and Mukai, K. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res. Treat.,49, 195-208 (1998).
16. Greenough, R. B. Varying degrees of malignancy in cancer of the breast. J. Cancer Res.,9, 453-463 (1925).
17. Patey, D. H. and Scarff, R. W. The position of histology in the prognosis of carcinoma of the breast. Lancet, i, 801-804 (1928).
18. Le Doussal, V., Tubiana-Hulin, M., Friedman, S., Hacene, K., Spyratos, F. and Brunet, M. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer, 64, 1914-1921 (1989).
19. Elston, C. W. and Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19, 403-410 (1991).
20. Todd, J. H., Dowle, C., Williams, M. R., Elston, C. W., Ellis, I. O., Hinton, C. P., Blamey, R. W. and Haybittle, J. L. Confirmation of a prognostic index in primary breast cancer. Br. J. Cancer, 56, 489-492 (1987).
21. Hermanek, P. and Sobin, L. H. "TNM Classification of Malignant Tumors," 4th Ed., p. 93 (1987). Springer-Verlag, Berlin.
22. Hasebe, T., Tsuda, H., Hirohashi, S., Shimosato, Y., Iwai, M., Imoto, S. and Mukai, K. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn. J. Cancer Res.,87, 385-394 (1996).
23. World Health Organization. Histological typing of breast tumors. In "International Histological Classification of Tumors," 2nd Ed., p. 18 (1981). World Health Organization, Geneva.
24. Kaplan, E. L. and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc.,53, 457-481 (1958).
25. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R. and Howard, S. V. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35, 1-39 (1977).
26. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc.,34, 187-220 (1972).